September 2024
1. FRIEDMAN JH
   In early Parkinson disease, daily subcutaneous lixisenatide reduced motor disability progression at 12 mo.
   Ann Intern Med. 2024 Sep 3. doi: 10.7326/ANNALS-24-01662.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share